Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
With such hectic schedules, even the most together families can get frazzled. What’s a busy family to do in order to keep their cool? Award winning health, nutrition and lifestyle expert Sharon Liao is here to help! She is available to provide helpful tips to help families stay organized and on top of their hectic schedules, especially when it comes to meal times. Sharon is ready to discuss everything from time management and juggling family time around hectic schedules, to tips on being efficient during meal times and how all families can stay on the right nutrition and fitness track.
The Sanford Guide, recognized as the essential reference for infectious disease treatment, announced the release of its first mobile app for the iPhone, iPod touch and iPad. The Sanford Guide App, available on Apple’s App Store for $29.99, contains the comprehensive guidelines and recommendations featured in the well-known pocket-size guides used by health care professionals in treatment decision making for over 40 years.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sanfordguide/50808/
Children International, a leading humanitarian organization, is providing fuel-efficient Ecocina cookstoves that can save lives among poor families in rural Honduras. The stoves are also better for the environment because they reduce wood consumption and harmful pollutants – a great reason to celebrate on Earth Day. In stark contrast to modern kitchens where burners can be turned on and off at will, “kitchens” in rural areas of the developing world often consist of open flames inside highly flammable primitive homes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57996-children-international-provides-stoves-that-save-lives-in-latin-america
Sabra Dipping Company, maker of America’s best-selling hummus, has launched the most significant campaign in U.S. hummus history and along with it… a more mindful pre-dinner meal occasion for the American consumer. A national broadcast and digital campaign introduces the ‘Unofficial Meal,’ inviting consumers to foster a pre-dinner ritual that revolves around fresh, real food and human connections.
“We are on a mission to inspire consumers to start a tradition around the kitchen counter, creating a daily ritual of enjoying fresh food together,” said Eugenio Perrier, Sabra’s chief marketing officer. “Eating wholesome food should be easy as should finding fresh ways to create connections, embrace those you care about and enjoy a relaxed moment together. It is this sentiment we seek to bring to life through the Unofficial Meal.”
The campaign titled “Sabra. Welcome to the Unofficial Meal” debuts April 18th with 15 and 30 second spots that depict the Unofficial Meal as family and friends finally unwind, gather and graze after a long day. Fresh dips and vegetables are laid out on the countertop and it is clear that for this moment, it is perfectly fine to help yourself, open up, share a laugh and leave behind formalities. The creative includes filmed footage, animation and a charismatic voice to convey the enjoyment of this occasion. Fully integrated digital, PR, social and experiential activations will help deliver campaign messaging across platforms.
To view the multimedia release go to:
http://www.multivu.com/players/English/7754651-sabra-campaign-unofficial-meal/
A Cigna Foundation grant to Achilles International will help determine whether running holds the key to better mental and physical development for children with autism. The Cigna Foundation today announced its $100,000 World of Difference grant to Achilles International, which has extensive anecdotal evidence showing that walking and running help people on the autism spectrum improve their emotional and physical health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7252851-cigna-foundation-achilles-international-running-autism-study-grant/
National blood stocks have fallen by 7% over the jubilee weekend according to latest figures from NHS Blood and Transplant (NHSBT) which today launches its annual awareness campaign, National Blood Week, to urge the public to donate blood.
During the National Blood Week recruitment drive additional appointments have been created and selected blood donor sessions have extended opening hours to give donors more flexibility to schedule a visit. Regional recruitment events will also be driving awareness and enabling people to sign up.
To launch the 2012 National Blood Week, Made In Chelsea’s Rosie Fortescue has rolled her sleeves up to recreate the heroic ‘Rosie the Riveter’ WWII poster and issue a rallying cry for new and existing blood donors to come forward. Rosie Fortescue, who shares her name with the 1940s poster girl, said: “This woman clearly knew how to get things done, and I feel honoured to become a modern day campaigner for the national blood stock build. Blood supplies are vital to the health service and every unit of blood can save or improve the lives of up to three people.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/56548-nhs-blood-transplant
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Not being able to see well is no laughing matter. That’s why nationally renowned standup comedian and radio personality Rickey Smiley has teamed up with America’s Best Contacts & Eyeglasses to create the Rickey Smiley Eyewear line and give more people the opportunity to see well and look good, too. Now available in 12 styles, these fashion-forward frames feature hot color combinations and distinguished finishes and textures – and are reasonably priced.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7308451-america-s-best-rickey-smiley-launch-stylish-affordable-fashion-frames-eyewear/
The science of bionics helped the more than 1 million Americans with leg amputations take a giant step forward, as the Rehabilitation Institute of Chicago (RIC) revealed clinical applications for the world’s first thought-controlled bionic leg in this week’s New England Journal of Medicine. This innovative technology represents a significant milestone in the rapidly-growing field of bionics. Until now, only thought-controlled bionic arms were available to amputees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63339-rehabilitation-institute-of-chicago-first-thought-controlled-bionic-leg
Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
